On January 9, 2018, Dr. Annalisa Jenkins, notified OncoSec Medical Incorporated of her resignation from the Board of Directors, effective immediately. Concurrently with such resignation, Dr. Jenkins ceased to serve as a member of the Audit Committee, Compensation Committee, Nominating & Corporate Governance Committee and Finance and Business Development Committee of the Board. On January 12, 2018, following the company's annual meeting of stockholders, the Board appointed Gregory T. Mayes to serve as a director on the Company's Board of Directors and as a member of the Audit Committee and Compensation Committee of the Board of Directors. Mr. Mayes has served as the president, chief executive officer, founder and a member of the board of directors of Engage Therapeutics Inc. Mr. Mayes also served as a member of the board of directors of Advaxis from March 2016 to April 2017.